Results

Total Results: 1,892 records

Showing results for "drugs".

  1. www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/final-drugs-for-covid.pdf
    June 02, 2025 - , Medical Expenditure Panel Survey Research Findings #49: Pre-COVID Retail Use and Expenditures for DrugsDrugs to Treat COVID-19 a respiratory agent Albuterol Azithromycin 17 million per year 14 million … per year used by used by Most widely prescribed retail and mail-order drugs in 2014-2018 that
  2. www.ahrq.gov/data/infographics/drugs-covid.html
    August 01, 2021 - Drugs to Treat COVID   Drugs to Treat COVID (PDF, 459 KB) Source:  AHRQ, Medical Expenditure … Panel Survey Research Findings #49, Pre-COVID Retail Use and Expenditures for Drugs That Were Subsequently
  3. www.ahrq.gov/data/visualizations/retail-drugs-covid-19.html
    January 01, 2022 - Retail and Mail Order Drugs Used in 2014-18 and Later Prescribed For COVID-19 The coronavirus … use of and expenditures for these medications before COVID-19 informs our understanding of how the drugs … ’ new uses may cause shortages or price increases that affect people who used these drugs before the … Source: AHRQ MEPS Research Findings #49: Pre-COVID-19 Retail Use and Expenditures for Drugs That Were … This information is used to present the percent distribution of conditions associated with drugs that
  4. www.ahrq.gov/data/infographics/retail-drug.html
    April 01, 2021 - Reduced Median Annual Spending for Retail Drugs by People Under Age 65 Reduced Median Annual … Spending for Retail Drugs by People Under Age 65 (PDF, 1.2 MB) Source: AHRQ, Medical Expenditure … Panel Survey Statistical Brief #532: Out-of-Pocket Spending for Retail Prescription Drugs by Age and
  5. www.ahrq.gov/news/newsroom/case-studies/201539.html
    January 01, 2016 - AHRQ's Evidence-based Practice Centers Program to inform consumers and clinicians about prescription drugs … The non-profit organization's Best Buy Drugs public education project compares medications' track records … "We've used the AHRQ evidence reports for many of the Best Buy Drugs reports we've produced," he noted … Best Buy Drugs reports based on AHRQ evidence reviews receive wide distribution, either through the … For example, information in Consumer Reports Best Buy Drugs publication on Alzheimer's disease drugs
  6. www.ahrq.gov/patients-consumers/patient-involvement/off-label-drug-usage.html
    September 01, 2015 - Off-Label Drugs: What You Need to Know Off-label prescribing is when a physician gives you a … effectiveness of this practice through these additional resources: Little difference in effectiveness of drugs … Maryland Guides Prescribers on Use of Atypical Antipsychotic Medications Understanding Investigational Drugs … and Off Label Use of Approved Drugs Off-Label Drug Use in Cancer Treatment Consumer Reports Best … Buy Drugs: Off-label prescription drugs Related Links Read Dr.
  7. www.ahrq.gov/sites/default/files/2024-01/kesselheim-report.pdf
    January 01, 2024 - , neuropsychiatric drugs, and drugs for other rare diseases. … Second, I identified selected drugs in three target categories—neuropsychiatric drugs, oncologic drugs … , and drugs for other rare diseases. … orphan drugs and found that off-label uses predominate in orphan drugs used for popular “symptoms” … Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower
  8. www.ahrq.gov/topics/medication.html
    Resources Preguntas que debe hacer antes de tomar el medicamento Retail and Mail Order Drugs
  9. www.ahrq.gov/topics/data-data-visualization.html
    Data Visualizations Retail and Mail Order Drugs Used in 2014-18 and Later Prescribed For COVID-
  10. www.ahrq.gov/topics/covid-19.html
    Safety Long COVID is a Case Study of Our Fractured Healthcare System Retail and Mail Order Drugs
  11. www.ahrq.gov/news/newsletters/e-newsletter/943.html
    January 01, 2025 - Recent Evidence Indicates a Flourishing Market for Biosimilar Drugs Issue Number 943 AHRQ … Today's Headlines: Recent Evidence Indicates a Flourishing Market for Biosimilar Drugs . … Recent Evidence Indicates a Flourishing Market for Biosimilar Drugs An AHRQ-supported article in Health … Affairs discusses the potential of biosimilar drugs to unlock lower drug prices for patients. … Biosimilars are much more affordable versions of comparable brand-name biologic drugs.
  12. www.ahrq.gov/sites/default/files/2024-01/basco-report.pdf
    January 01, 2024 - For dosing frequency determination, we focused on narcotic-containing drugs prescribed to children 0 … This approach had the effect of censuring < 0.01% of prescriptions for the 22 drugs. … Determining drugs to evaluate for narcotic overdosing. … However, the PPV for 7/17 (41%) drugs that triggered an alert remained ≥ 10%. E-1b. … Retrospective detection of potential medication errors involving drugs with similar names.
  13. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/tools/cauti-ltc/modules/resources/tools/reduce/when-need-antibiotic.pdf
    March 01, 2017 - (17)-0003-17-EF March 2017 http://www.cdc.gov/longtermcare/resident/index.html http://www.fda.gov/Drugs … /ResourcesForYou/UCM078484 Antibiotics: Powerful Drugs, But Only When Used for the Right Reasons Antibiotic … drugs are strong medicine that can save lives when used appropriately to treat bacterial infections … It is important for us all that these powerful drugs are used only when they can help, so they will … Antibiotics can help the body fight bacterial infections, but they are not miracle drugs for everything
  14. www.ahrq.gov/sites/default/files/2024-01/magid-report.pdf
    January 01, 2024 - chronic renal insufficiency (Renal Intervention); b) lab monitoring of patients receiving high-risk drugs … Lab monitoring of patients receiving high-risk drugs (Lab Monitoring Intervention) c. … There were 20,000+ patients prescribed high-risk drugs that required lab monitoring. … at risk of having these drugs accumulate, with resulting increases in risk of drug toxicity. … combinations, spironolactone), whereas some low-yield drugs were removed.
  15. www.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
    January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs
  16. www.ahrq.gov/hai/quality/tools/cauti-ltc/modules/resources/tools/reduce/antibiotic-brochure.html
    March 01, 2017 - Resources for You CDC: http://www.cdc.gov/longtermcare/resident/index.html FDA: www.fda.gov/Drugs … /ResourcesForYou/UCM078484 Antibiotics: Powerful Drugs, But Only When Used for the Right Reasons … Antibiotic drugs are strong medicine that can save lives when used appropriately to treat bacterial infections … It is important for us all that these powerful drugs are used only when they can help, so they will work … Antibiotics can help the body fight bacterial infections, but they are not miracle drugs for everything
  17. www.ahrq.gov/patients-consumers/diagnosis-treatment/treatments/btpills/stayactive-tr.html
    September 01, 2015 - we'll attempt to address some of your concerns and answer many of the questions you may have about the drugs … Perhaps you've been wondering what these drugs do and why you need to take them. … Now let's talk about the drugs themselves. What are blood thinners? What do they do? … First the drugs are referred to as anticoagulants.
  18. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/ced-appendix2-comments.xlsx
    June 02, 2025 - Drugs and devices that are subject to CED should qualify for Medicare transitional pass-through status … Application of CED to on-label uses of drugs and biologicals restricts patient access. … Caution against the broad use of CED for on-label uses of drugs and biologics that have gone through … Ban CED for drugs with accelerated approval. … Recommends that on-label uses of drugs and biologicals be excluded from CED restrictions.
  19. www.ahrq.gov/sites/default/files/2024-01/lambert-report.pdf
    January 01, 2024 - Drug name confusion causes patients to receive the wrong drugs. … This book is in nontechnical language and is important because the safety of pharmaceutical products … Analysis of suicide attempts and self-harm for 949 drugs revealed nine drugs associated with increased … risk and 28 drugs associated with decreased risk. … (referred to as control drugs) available in the market.
  20. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Raebel_53.pdf
    May 07, 2008 - (Critical Drug Interactions); (2) receive anticoagulation treatment and are prescribed drugs that … interact with warfarin (Warfarin-Drug Interactions); (3) receive high-risk drugs requiring laboratory … (decrease) • N = 555 instances of codispensing of 8 pairs of interacting drugs … • Patients dispensed contraindicated drugs: o Usual care group, 5.5%. … Study demonstrated importance of monitoring drugs with toxicity risk.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: